The modulating effects of vitamin D on the activity of β-catenin in the endometrium of women with endometriosis: a randomized exploratory trial

Pazhohan A, Azar Pazhohan, Shahla Danaei-Mehrabad, Danaei-Mehrabad S, Mohamad-Rezaeii Z, Zhila Mohamad-Rezaeii, Fardin Amidi, Amidi F, Khodarahmian M, Mahshad Khodarahmian, Maryam Shabani Nashtaei, Shabani Nashtaei M, Aligholi Sobhani, Sobhani A, Farajzadeh MA, Mir Ali Farajzadeh
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2020 · vol. 37(3) , pp. 278–282 · doi:10.1080/09513590.2020.1858780 · PMID:33305626 · W3111970524
RCT OA: closed CC0 ⤵ 9 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This randomized trial found that weekly vitamin D supplementation for 12–14 weeks reduced the expression and activity of β-catenin in the endometrium of women with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIMS: The aim of this prospective study was to investigate the effects of vitamin D on the expression and activity of β-catenin, as the key molecule of the Wnt/β-catenin signaling pathway, in endometriosis women. MATERIALS AND METHODS: Thirty four infertile women with stage III or IV endometriosis were randomly divided to two groups. The control group received the routine treatment and the treatment group, beside the routine protocol, received 50000 IU vitamin D weekly for 12-14 weeks. Blood and endometrial tissue were collected from both groups before and after the intervention. Protein and Gene expression levels of β-catenin were assessed by Western blotting and Real-Time PCR, respectively. RESULTS: Compared to before intervention, the expression of active form of β-catenin reduced significantly within treatment group (p = .000), in addition, the difference between control and treatment groups (p = .012) was significant after intervention, too. Also, the ratio of active/total form of β-catenin protein expression was significantly decreased within the treatment group at the end of intervention period (p = .000). CONCLUSIONS: It seems vitamin D can change the activity of β-catenin protein in the endometrial cells of endometriosis patients. Further studies on the therapeutic potential of vitamin D in modifying the β-catenin activity in endometriosis patients are warranted. CLINICAL TRIAL REGISTRATION NUMBER: IRCT2015081823678N1. TRIAL REGISTRATION DATE: 29 September 2015.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

beta Catenin Endometriosis Endometrium Vitamin D Adult Adult beta Catenin beta Catenin beta Catenin beta Catenin Case-Control Studies Case-Control Studies Endometriosis Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Female

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (29)

Cited by (11)

Source provenance

europepmc
last seen: 2026-10-14T06:08:39.101224+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:29:19.503995+00:00
License: CC0 · commercial use OK